HIGHLIGHTS
- who: Catalina Lodillinsky from the Translational Research Department, RT Lab Team, INSERM, Immunity and Cancer, Institut Curie, Paris, France have published the research: Metastasis-suppressor NME1 controls the invasive switch of breast cancer by regulating MT1-MMP surface clearance, in the Journal: (JOURNAL)
- what: The authors report that NME1 is upregulated in ductal carcinoma in situ (DCIS) as compared to normal breast epithelial tissues. The authors propose NME1 as a potential marker to predict in situ tumors with high risk to progress into invasive breast carcinomatous lesions, which remains a critical issue in breast cancer . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.